381 related articles for article (PubMed ID: 19047164)
21. Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug.
Lu JY; Lowe DA; Kennedy MD; Low PS
J Drug Target; 1999; 7(1):43-53. PubMed ID: 10614814
[TBL] [Abstract][Full Text] [Related]
22. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors.
Lu Y; Low PS
Cancer Immunol Immunother; 2002 May; 51(3):153-62. PubMed ID: 11941454
[TBL] [Abstract][Full Text] [Related]
23. Antifolates targeted specifically to the folate receptor.
Jackman AL; Theti DS; Gibbs DD
Adv Drug Deliv Rev; 2004 Apr; 56(8):1111-25. PubMed ID: 15094210
[TBL] [Abstract][Full Text] [Related]
24. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate.
Moon WK; Lin Y; O'Loughlin T; Tang Y; Kim DE; Weissleder R; Tung CH
Bioconjug Chem; 2003; 14(3):539-45. PubMed ID: 12757377
[TBL] [Abstract][Full Text] [Related]
25. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
Chiu SJ; Marcucci G; Lee RJ
Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
[TBL] [Abstract][Full Text] [Related]
26. Improvement of meta-tetra(hydroxyphenyl)chlorin-like photosensitizer selectivity with folate-based targeted delivery. synthesis and in vivo delivery studies.
Gravier J; Schneider R; Frochot C; Bastogne T; Schmitt F; Didelon J; Guillemin F; Barberi-Heyob M
J Med Chem; 2008 Jul; 51(13):3867-77. PubMed ID: 18553957
[TBL] [Abstract][Full Text] [Related]
27. Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery.
Paulos CM; Reddy JA; Leamon CP; Turk MJ; Low PS
Mol Pharmacol; 2004 Dec; 66(6):1406-14. PubMed ID: 15371560
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.
Kukowska-Latallo JF; Candido KA; Cao Z; Nigavekar SS; Majoros IJ; Thomas TP; Balogh LP; Khan MK; Baker JR
Cancer Res; 2005 Jun; 65(12):5317-24. PubMed ID: 15958579
[TBL] [Abstract][Full Text] [Related]
29. Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy.
Sega EI; Lu Y; Ringor M; Leamon CP; Low PS
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):559-66. PubMed ID: 18411004
[TBL] [Abstract][Full Text] [Related]
30. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice.
Yamada A; Taniguchi Y; Kawano K; Honda T; Hattori Y; Maitani Y
Clin Cancer Res; 2008 Dec; 14(24):8161-8. PubMed ID: 19088031
[TBL] [Abstract][Full Text] [Related]
31. Tumor detection using folate receptor-targeted imaging agents.
Sega EI; Low PS
Cancer Metastasis Rev; 2008 Dec; 27(4):655-64. PubMed ID: 18523731
[TBL] [Abstract][Full Text] [Related]
32. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates.
Yang J; Chen H; Vlahov IR; Cheng JX; Low PS
J Pharmacol Exp Ther; 2007 May; 321(2):462-8. PubMed ID: 17289839
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors.
Bettio A; Honer M; Müller C; Brühlmeier M; Müller U; Schibli R; Groehn V; Schubiger AP; Ametamey SM
J Nucl Med; 2006 Jul; 47(7):1153-60. PubMed ID: 16818950
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting.
Tran T; Shatnawi A; Zheng X; Kelley KM; Ratnam M
Cancer Res; 2005 May; 65(10):4431-41. PubMed ID: 15899836
[TBL] [Abstract][Full Text] [Related]
36. Folate-mediated targeting of therapeutic and imaging agents to cancers.
Reddy JA; Low PS
Crit Rev Ther Drug Carrier Syst; 1998; 15(6):587-627. PubMed ID: 9883391
[TBL] [Abstract][Full Text] [Related]
37. Characterization of folate receptor from normal and neoplastic murine tissue: influence of dietary folate on folate receptor expression.
Gates SB; Mendelsohn LG; Shackelford KA; Habeck LL; Kursar JD; Gossett LS; Worzalla JF; Shih C; Grindey GB
Clin Cancer Res; 1996 Jul; 2(7):1135-41. PubMed ID: 9816279
[TBL] [Abstract][Full Text] [Related]
38. Single-chain Fv/folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells.
Cho BK; Roy EJ; Patrick TA; Kranz DM
Bioconjug Chem; 1997; 8(3):338-46. PubMed ID: 9177839
[TBL] [Abstract][Full Text] [Related]
39. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
40. Real time, noninvasive imaging and quantitation of the accumulation of ligand-targeted drugs into receptor-expressing solid tumors.
Vlashi E; Sturgis JE; Thomas M; Low PS
Mol Pharm; 2009; 6(6):1868-75. PubMed ID: 19754150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]